Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03226548 · ClinicalTrials.gov registry record · NA
Effect of EITC on Biological Markers of Aging, Health and Mortality
A NA study of Poverty and Tax Policy, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,350
- Enrollment target
- 1
- Study location
NCT03226548: Completed NA study of Poverty and Tax Policy, sponsored by Columbia University.
NCT03226548 is a NA study of Poverty and Tax Policy that has completed, run by Columbia University. The registered enrollment target is 1,350 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03226548, a NA study of Poverty and Tax Policy, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,350 participants
- Enrollment target
- 1
- Study location
Study Summary
Paycheck Plus (PP) is a randomized controlled experiment (RCT) that explores the health and longevity effects associated with increasing the Earned Income Tax Credit (EITC). EITC is a national program that provides tax credits to low-income, disproportionately minority workers who file taxes. EITC is politically popular, having received bipartisan support. The EITC, along with state supplemental programs, have 7 million American families out of poverty. The investigators' preliminary data analyses show that the EITC has had large population health impacts, reversing declines in self rated health and survival among the poorest Americans.
Primary Outcome
Depression will be measured using the subject's score on the PHQ-9.
Conditions Studied
Interventions
- OTHER Paycheck Plus
Study Locations (1)
Georgia
- Westat - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2016-12-20 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT03226548 record still lists
NCT03226548 is an interventional study that assigns participants to a tested intervention. Its 1,350 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 2 conditions, with Poverty appearing as the primary indexed condition, and to 1 intervention - of which Paycheck Plus is the first listed.
NCT03226548 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03226548 about?
NCT03226548 is a clinical study titled "Effect of EITC on Biological Markers of Aging, Health and Mortality". Paycheck Plus (PP) is a randomized controlled experiment (RCT) that explores the health and longevity effects associated with increasing the Earned Income Tax Credit (EITC). EITC is a national program that provides tax credits to low-income, disproportionately minority workers who file taxes. EITC i...
What is the current status of trial NCT03226548?
This trial is currently completed. It is a NA study. The enrollment target is 1,350 participants. The study started on 2016-12-20. Estimated completion is 2021-12-31.
What conditions does trial NCT03226548 study?
This clinical trial studies the following conditions: Poverty, Tax Policy.
What interventions are being tested in trial NCT03226548?
The interventions under investigation include: Paycheck Plus (OTHER).
Who is sponsoring clinical trial NCT03226548?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03226548 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Poverty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03226548's enrollment target sits among peer trials
1,350 73rd of 2000 higher than 1,927 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI